Looking for volunteers
Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
NCT06715878 · RenJi Hospital · Updated 10 Dec 2024
- What is being tested
- Zero Ischemia Robot-Assisted Laparoscopic Microwave Ablation Assisted suture-less Enucleation; robotic-assisted laparoscopic partial nephrectomy
- For
- Kidney Neoplasms
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 15 years to 80 years. About 80 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 March 2024, ends 31 Dec 2025. Registered 4 Dec 2024.
- Results
- None posted yet.
In the researchers' words
Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been proved to enable tumor excision with relatively better renal function preservation comparing with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a randomized clinical trial in single center. The investigators want to explore this technique to robotic surgery and add suture-less technique to T1 RCC patients in randomized clinical trial.
Sites
- Ethics Committee of Shanghai Renji HospitalShanghai, China